Quick amplification detection kit of SNP (single nucleotide polymorphism) site of MTRR (5-methyltetrahydrofolate-homocysteinemethyltransferase reductase) and detection method
A technology for detection kits and detection methods, which is applied in the detection of biological samples and in the field of biology, can solve the problems of increasing the economic burden of the testee, high detection cost, and long detection time, so as to reduce economic and mental burden, high detection efficiency, Get the effect in a short time
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2019-03-15
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a rapid amplification detection kit and detection method of SNP sites of MTRR, belonging to the field of biotechnology, especially the field of biological sample detection. Background technique
[0002] Methionine synthase reductase MTRR (5-methyltetrahydrofolate-homocysteinemethyltransferase reductase), the full name is encoding 5-methyltetrahydrofolate-homocysteine methyltransferase reductase. Methionine is an essential amino acid for protein synthesis and one-carbon metabolism. Its synthesis is catalyzed by methionine synthase (encoded by the MTR gene), and methionine synthase is eventually oxidized due to the oxidation of the cofactor vitamin B12. Inactivate. The methionine synthase reductase encoded by MTRR can regenerate functionally active methionine synthase through reductive methylation. MTRR mutation is the main cause of folic acid / methyl vitamin deficiency type E, and it is also one of the main causes of abnormal...
Examples
Embodiment Construction
[0035] The rapid amplification detection kit and detection method of the SNP site of MTRR provided by the present invention will be further described in detail and completely in conjunction with the examples below. The embodiments described below are exemplary only for explaining the present invention and should not be construed as limiting the present invention.
[0036]The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples were purchased from the market unless otherwise specified.
[0037] The instruments and reagents adopted in the present invention are as follows:
[0038] PTC-255 PCR amplification instrument, MJ Research, USA;
[0039] Pyrosequencer, Wuhan First Biotechnology Co., Ltd.;
[0040] TaqDNA polymerase, dNTPs (10mmol / L), 10×Buffer and MgCl 2 (25mmol / L) (Dalian TaKaRa company); AmpliTaqGold polymerase (AppliedBiosystems company); KlenowFragment (no exon...